Glucocorticoid-induced_JJ
apoptosis_NN
of_IN
human_JJ
leukemic_JJ
cells_NNS
is_VBZ
caused_VBN
by_IN
the_DT
repressive_JJ
function_NN
of_IN
the_DT
glucocorticoid_NN
receptor_NN
._.

Induction_NN
of_IN
apoptosis_NN
in_IN
lymphocytes_NNS
,_,
which_WDT
may_MD
account_VB
for_IN
the_DT
therapeutic_JJ
effects_NNS
of_IN
glucocorticoids_NNS
in_IN
various_JJ
diseases_NNS
including_VBG
leukemia_NN
,_,
depends_VBZ
on_IN
the_DT
glucocorticoid_NN
receptor_NN
._.

However_RB
,_,
the_DT
events_NNS
leading_VBG
from_IN
the_DT
activated_VBN
receptor_NN
to_TO
cell_NN
lysis_NN
are_VBP
not_RB
understood_VBN
._.

A_DT
prevailing_VBG
hypothesis_NN
postulates_VBZ
induction_NN
of_IN
so-called_JJ
'_``
lysis_NN
genes_NNS
'_''
by_IN
the_DT
activated_VBN
receptor_NN
._.

In_IN
this_DT
study_NN
,_,
we_PRP
show_VBP
that_IN
an_DT
activation-deficient_JJ
glucocorticoid_NN
receptor_NN
mutant_NN
is_VBZ
as_RB
effective_JJ
as_IN
the_DT
wild-type_JJ
receptor_NN
in_IN
repression_NN
of_IN
AP-1_NN
activity_NN
,_,
inhibition_NN
of_IN
interleukin-2_NN
production_NN
,_,
inhibition_NN
of_IN
c-myc_NN
expression_NN
and_CC
induction_NN
of_IN
apoptosis_NN
._.

Furthermore_RB
,_,
we_PRP
show_VBP
that_IN
retinoic_JJ
acid_NN
can_MD
also_RB
induce_VB
apoptosis_NN
in_IN
these_DT
cells_NNS
through_IN
the_DT
retinoic_JJ
acid_NN
receptor_NN
,_,
whose_WP$
repressive_JJ
functions_NNS
but_CC
not_RB
target_NN
site_NN
specificity_NN
,_,
are_VBP
similar_JJ
to_TO
those_DT
of_IN
the_DT
glucocorticoid_NN
receptor_NN
._.

Therefore_RB
,_,
the_DT
primary_JJ
effect_NN
of_IN
the_DT
receptor_NN
in_IN
glucocorticoid-mediated_JJ
apoptosis_NN
correlates_VBZ
with_IN
transcriptional_JJ
repression_NN
rather_RB
than_IN
activation_NN
and_CC
could_MD
be_VB
mediated_VBN
by_IN
interference_NN
with_IN
other_JJ
transcription_NN
factors_NNS
required_VBN
for_IN
cell_NN
survival_NN
._.

